Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Medullary × Gefitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 3 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 EGFR-mutant Non-small Cell Lung Cancer 1 Brain Neoplasms 1

Interventions

selpercatinib 5 vandetanib 4 cabozantinib 3 Magnetic Resonance Spectroscopy 3 pralsetinib 1 fluorodopa F 18 1 fludarabine 1 Sunitinib 1 Standard of Care 1 Specimen Handling 1 Radiofrequency Ablation 1 Practice Guidelines as Topic 1 Pharmacogenomic Testing 1 Nivolumab 1 Laser Therapy 1 Interviews as Topic 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Decision Support Techniques 1 Cyclophosphamide 1 Cryosurgery 1 Cryoelectron Microscopy 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡